Xthetix

Xthetix is a clinical-stage biotechnology company focused on the development of next-generation regenerative aesthetic products. The company's core technology involves a proprietary synthetic, bio-resorbable polymer platform designed for soft tissue augmentation and dermal filling. Its lead product candidate, XT-001, is an injectable filler currently in Phase 2 clinical development for the correction of moderate-to-severe nasolabial folds. Xthetix's products are engineered to provide enhanced durability and natural integration compared to existing hyaluronic acid-based treatments. The company aims to bridge the gap between temporary fillers and permanent implants by offering a safe, long-lasting solution for facial rejuvenation. Headquartered in San Francisco, Xthetix is led by a management team with extensive experience in the medical aesthetics industry.